BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1789 related articles for article (PubMed ID: 25128467)

  • 1. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
    Shukla S; Rizvi F; Raisuddin S; Kakkar P
    Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent acetylation of FoxO1/3a and p53 due to sirtuins inhibition elicit Bim/PUMA mediated mitochondrial dysfunction and apoptosis in berberine-treated HepG2 cells.
    Shukla S; Sharma A; Pandey VK; Raisuddin S; Kakkar P
    Toxicol Appl Pharmacol; 2016 Jan; 291():70-83. PubMed ID: 26712469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18β-glycyrrhetinic acid induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells.
    Sharma G; Kar S; Palit S; Das PK
    J Cell Physiol; 2012 May; 227(5):1923-31. PubMed ID: 21732363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway.
    Boreddy SR; Pramanik KC; Srivastava SK
    Clin Cancer Res; 2011 Apr; 17(7):1784-95. PubMed ID: 21350002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin receptor substrate-1 and -2 mediate resistance to glucose-induced caspase-3 activation in human neuroblastoma cells.
    Stöhr O; Hahn J; Moll L; Leeser U; Freude S; Bernard C; Schilbach K; Markl A; Udelhoven M; Krone W; Schubert M
    Biochim Biophys Acta; 2011 May; 1812(5):573-80. PubMed ID: 21354306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells.
    Obexer P; Geiger K; Ambros PF; Meister B; Ausserlechner MJ
    Cell Death Differ; 2007 Mar; 14(3):534-47. PubMed ID: 16888645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine induced modulation of PHLPP2-Akt-MST1 kinase signaling is coupled with mitochondrial impairment and hepatoma cell death.
    Saxena S; Shukla S; Kakkar P
    Toxicol Appl Pharmacol; 2018 May; 347():92-103. PubMed ID: 29626488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXO3-mediated up-regulation of Bim contributes to rhein-induced cancer cell apoptosis.
    Wang J; Liu S; Yin Y; Li M; Wang B; Yang L; Jiang Y
    Apoptosis; 2015 Mar; 20(3):399-409. PubMed ID: 25501496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells.
    Carbajo-Pescador S; Steinmetz C; Kashyap A; Lorenz S; Mauriz JL; Heise M; Galle PR; González-Gallego J; Strand S
    Br J Cancer; 2013 Feb; 108(2):442-9. PubMed ID: 23257900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
    Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms.
    Paraiso KH; Haarberg HE; Wood E; Rebecca VW; Chen YA; Xiang Y; Ribas A; Lo RS; Weber JS; Sondak VK; John JK; Sarnaik AA; Koomen JM; Smalley KS
    Clin Cancer Res; 2012 May; 18(9):2502-14. PubMed ID: 22351686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells.
    Guan H; Song L; Cai J; Huang Y; Wu J; Yuan J; Li J; Li M
    PLoS One; 2011; 6(5):e19946. PubMed ID: 21625639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol induces apoptosis through modulation of the Akt/FoxO3a/Bim pathway in HepG2 cells.
    Liu MH; Lin XL; Li J; He J; Tan TP; Wu SJ; Yu S; Chen L; Liu J; Tian W; Chen YD; Fu HY; Yuan C; Zhang Y
    Mol Med Rep; 2016 Feb; 13(2):1689-94. PubMed ID: 26709007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
    Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
    Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXO3a mediates the cytotoxic effects of cisplatin in lung cancer cells.
    Liu H; Yin J; Wang C; Gu Y; Deng M; He Z
    Anticancer Drugs; 2014 Sep; 25(8):898-907. PubMed ID: 24814195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
    Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
    Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHIP regulates AKT/FoxO/Bim signaling in MCF7 and MCF10A cells.
    Lv Y; Song S; Zhang K; Gao H; Ma R
    PLoS One; 2013; 8(12):e83312. PubMed ID: 24376685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity.
    Dijkers PF; Birkenkamp KU; Lam EW; Thomas NS; Lammers JW; Koenderman L; Coffer PJ
    J Cell Biol; 2002 Feb; 156(3):531-42. PubMed ID: 11815629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo.
    Shao H; Gao C; Tang H; Zhang H; Roberts LR; Hylander BL; Repasky EA; Ma WW; Qiu J; Adjei AA; Dy GK; Yu C
    J Hepatol; 2012 Jan; 56(1):176-83. PubMed ID: 21835141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of FoxO3a/Bim axis in patients with Primary Biliary Cirrhosis.
    Kopycinska J; Kempińska-Podhorodecka A; Haas T; Elias E; DePinho RA; Paik J; Milkiewicz P; Milkiewicz M
    Liver Int; 2013 Feb; 33(2):231-8. PubMed ID: 23295054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 90.